Chronic hives: Researchers identify most effective, safest treatments
A new international study led by researchers at McMaster University has identified the most effective and safest treatments for people suffering from chronic urticaria, more commonly known as chronic hives.
Published in The Journal of Allergy and Clinical Immunology on July 15, 2025, the study is the first comprehensive network meta-analysis to compare more than 40 treatment options for chronic hives, a condition that affects about one per cent of people and can severely impact quality of life, sleep, and productivity. The study examined 93 randomized controlled trials involving over 11,000 participants.
Prior to now, patients and clinicians had to consult a growing list of treatment options without up-to-date evidence.
The research identified the following treatments as most effective:
- Omalizumab, an injectable antibody, and remibrutinib, a new oral medication, are among the most effective treatments for reducing hives, itch, and swelling.
- Dupilumab, another injectable antibody, also showed promise, particularly for reducing hives.
- Cyclosporine may be effective but carries a higher risk of side-effects such as kidney toxicity and high blood pressure.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.